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Abstract
Cell cycle progression in eukaryotes is regulated by periodic activation and inactivation of a family of cyclin–dependent
kinases (Cdk’s). Entry into mitosis requires phosphorylation of many proteins targeted by mitotic Cdk, and exit from mitosis
requires proteolysis of mitotic cyclins and dephosphorylation of their targeted proteins. Mitotic exit in budding yeast is
known to involve the interplay of mitotic kinases (Cdk and Polo kinases) and phosphatases (Cdc55/PP2A and Cdc14), as well
as the action of the anaphase promoting complex (APC) in degrading specific proteins in anaphase and telophase. To
understand the intricacies of this mechanism, we propose a mathematical model for the molecular events during mitotic
exit in budding yeast. The model captures the dynamics of this network in wild-type yeast cells and 110 mutant strains. The
model clarifies the roles of Polo-like kinase (Cdc5) in the Cdc14 early anaphase release pathway and in the G-protein
regulated mitotic exit network.
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Introduction
The cell cycle plays a crucial role in all biological growth,
reproduction and development, and the molecular machinery
underlying the cell cycle is known to be highly conserved among
all eukaryotes [1]. Faithful transmission of genetic information
depends on accurate chromosome segregation as cells exit from
mitosis, and the penalty for errors in chromosome segregation is
severe; failures in this process lead to aneuploidy which is
responsible for many cases of spontaneous abortions, birth defects
and cancer [2]. In eukaryotes, an elaborate molecular control
system ensures the proper orchestration of events at mitotic exit
(ME). Understanding how cell division is controlled by this
network of interacting genes and proteins is clearly important to
the life sciences, the biotech industry and medical science.
The molecular events during ME are particularly well
delineated in budding yeast, Saccharomyces cerevisiae, for which a
large collection of well characterized ME-mutant strains are
available. From the phenotypes of these mutants, yeast geneticists
are able to propose a hypothetical network of interactions among
the proteins encoded by ME genes. However, the resulting
network (e.g., Figure 1) is so complex that it defies understanding
by intuitive reasoning alone. As an aid to intuition, we propose a
mathematical model of the ME control system. We show that the
model is consistent with the observed phenotypes of most ME-
mutants in budding yeast, and we use the model to predict the
behavior of the ME network under novel conditions. This
methodology has been used to advantage for many years to create
mathematical models of cell cycle regulation in fission yeast [3–8],
budding yeast [9], and mammalian cells [10]. Embryonic cell
cycles have been modeled in frog eggs [11], the fruit fly [12] and
the sea urchin [13]. Not only have these models reproduced large
amounts of experimental data, but also they have made successful
predictions and guided further experimental studies [14–16].
Since 2004, when Chen et al. [9] published their comprehensive
model of the budding yeast cell cycle, many more molecular
details of ME have come to light, and several updated models of
ME have been proposed [17–19]. In this paper, we present a
mathematical model of ME control, taking into account the
essential role that Polo kinase (Cdc5) plays in the phosphorylation
of Net1 and the subsequent release of Cdc14 from the nucleolus
[20]. We propose a novel mechanism for phosphorylation of Net1
on distinct sites by the ME-relevant kinases: Cdc28, Cdc5 and
Dbf2/Mob1 (through activation by Cdc15). The model also
integrates proteolytic and nonproteolytic functions of Esp1 into the
Cdc14 early anaphase release (FEAR) pathway and the mitotic
exit network (MEN). The model accounts for the observed
properties of ME in wild-type yeast cells and 110 mutant strains,
and it predicts the phenotypes of numerous mutant yeast cells that
have not yet been studied to our knowledge.
The precise molecular mechanism by which Cdc5 promotes
Net1 phosphorylation, FEAR activation, and ME is not known.
Cdc5 promotes FEAR activation in part by inducing degradation
of Swe1 (an inhibitor of Cdk/Clb2 activity), which enables Cdk/
Clb2 to phosphorylate Net1 [21]. Cdc5 reduces the affinity
between Net1 and Cdc14 [22]. Cdc5 phosphorylates Net1
extensively in vitro, and it may influence the phosphorylation state
of Net1 in vivo [23–25].
Our model of ME is based on well-known biochemical
interactions in budding yeast and on the assumption that Cdc5
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of Cdc14 from Net1 relies on Net1 being phosphorylated solely by
Cdc5 or being multiply phosphorylated by Cdk/Clb2, by MEN
and by Cdc5. In this paper, we gather all the evidence supporting
Net1 phosphorylation by Cdc5 in vivo on its own, using observed
phenotypes of mutant yeast cells to clarify the mechanism of
Cdc14 activation during ME.
The exact role of Polo kinase (Cdc5) in the ME process and the
exact mechanism by which Net1 gets phosphorylated and Cdc14
is released are the most controversial aspects of ME. Our view that
Net1 can be solely phosphorylated by Cdc5 has been challenged
by others [21]. Recent models of ME consider Net1 phosphor-
ylation to be dependent on Cdk and MEN-kinases [17,19]. In
Queralt’s model [17], Cdc5 cannot phosphorylate Net1 on its
own, and the essential role of Cdc5 in ME is attributed to its role
in MEN. Later on, Vinod et al. [19] extended Queralt’s model with
more cell cycle regulators, including Net1 phosphorylation by
Cdc5. However, Vinod’s model assumes that Net1 phosphoryla-
tion by Cdc5 is dependent on a priming phosphorylation by Cdk/
Clb2 or MEN kinases. At the heart of our model, unique to this
paper, lies the assumption that Cdc5 may phosphorylate Net1 on
its own, independent of Cdk and MEN phosphorylation.
For further contextualization, we refer readers to Text S1,
where we summarize some details of ME kinetics in budding yeast
and the interactions among major components of the control
system. In the next section, we provide details about how these
interactions are implemented in our mathematical model.
Results
A model for mitotic exit in budding yeast
Our proposed mechanism for ME in yeast (Figure 1) is
simplified by combining the roles of some of the cell cycle proteins
described in Text S1. For instance, we represent the two G1-
stabilizers (Cdh1 and Sic1) by a single variable, with the properties
of Cdh1. We combine the ‘mitotic cyclins’ (Clb1-4) into a single
variable, Clb2. We assume that Cdk subunits (Cdc28) are always
available to bind to Clb2, since Cdc28 is present in excess in cells.
Hence, the model focuses on the synthesis and degradation of
Clb2 and ignores fluctuations in Cdc28 level. Some proteins that
play known roles in the metaphase-anaphase-G1 transition (ME),
such as Sic1, Lte1, Bub2 and Bfa1, have been left out of the
present model. We plan to include them in a later version, along
with a representation of the chromosome alignment checkpoint.
For a discussion of the model’s assumptions, please see Text S2.
Our model focuses on the cell cycle transition from a stable
metaphase state (high Cdk activity, low Cdh1 activity) to a stable
G1 state (low Cdk activity and high Cdh1 activity). This transition
corresponds to a window of the cell cycle that has been frequently
studied experimentally by arresting cells in metaphase by Cdc20-
Figure 1. Proposed wiring diagram of mitotic exit control in the budding yeast cell cycle. For a full justification of this diagram with
references, see Texts S1 and S2. Cdc28, the kinase partner of Clb2, is not shown explicitly in this diagram. Cdc20 and Cdh1 work in collaboration with
the APC, which is also not shown explicitly in the diagram. All proteins (ovals) are assumed to be produced and degraded at specific rates. Four white
circles represent degraded proteins. Solid lines correspond to chemical reactions, while dashed lines denote regulatory effects (enzyme catalysis). A
protein sitting on a reaction arrow also represents an enzyme that catalyses the reaction. Cdc20 initiates the transition from metaphase to anaphase.
Cdc14 released from PRENT and PRENTP induces exit from mitosis, i.e., activation of Cdh1 and establishment of the cell in G1 phase.
doi:10.1371/journal.pone.0030810.g001
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readdition of Cdc20 or by overexpression of separase, e.g. [17].
In this article, we aim to clarify the factors affecting activation
and inactivation of FEAR and MEN pathways, the functions of
Cdc5 and Esp1 to promote ME, and the regulation of Cdc14
(release from and re-sequestration to the nucleolus) in the wild-
type cell cycle. Since the publication of Queralt’s model [17], new
molecular details of ME, especially regarding to the roles of Cdc5
[20] have come to light. To account for the experiments in
Visintin et al. [20] and many others, we have extended Queralt’s
model with some new components and interactions. Nonetheless,
the consensus picture of the regulation of most ME regulators
(summarized in Text S1) has not changed, so we retain from
Queralt’s model the same ODEs—or very similar ones—for these
ME regulators (Clb2, Cdc20, Pds1, Esp1, PE, Polo, Tem1, Cdc15
and MEN). The main challenge is to find out how these regulators
are wired together in ME pathways. We examined many
alternative scenarios. Each scenario is consistent with many
observed phenotypes but inconsistent with other important
observations. It is not our purpose in this paper to discuss all
these alternative scenarios but to present the one that we believe to
be the best.
Unique to our model, we propose a mechanism for Cdc14
regulation by multisite phosphorylation of Net1 by several kinases,
as depicted in Figure 1. We propose that Cdc5 may phosphorylate
Net1 in vivo on its own, either before or after Net1 is
phosphorylated by Cdk [23]. As opposed to the assumption of
Queralt’s model, which attributes the essential role of Cdc5 later in
ME as part of MEN, we consider Cdc5 as an essential component
of both MEN and FEAR pathways. We propose that Cdc5 can
induce Cdc14 release by phosphorylating Net1 directly even when
other components of FEAR and MEN pathways are silent [20].
Cdc15 acts only in the MEN pathway, downstream of Tem1 and
upstream of Dbf2/Mob1, the kinase that phosphorylates Net1
[26–29]. When Tem1 is inactive, overexpressed Cdc15 can still
activate MEN and sustain Cdc14 release [30]. To explain
overexpressed Cdc15 mutants when Tem1 is inactive, our model
assumes that active Cdc15 can phosphorylate Net1 on its own as
well. In the Queralt model, Cdc15 is part of the MEN complex,
which phosphorylates Net1, but Cdc15 cannot phosphorylate
Net1 on its own.
Key regulators of ME are the protease Esp1 [31] and the
phosphatase Cdc14 [32]. Active Esp1 promotes anaphase
(separation of sister chromatids) by cleaving cohesin rings. Esp1
is kept inactive in early M phase by binding to a stoichiometric
inhibitor, Pds1 (securin). Cdc14, when active, promotes ME by
dephosphorylating the proteins that were phosphorylated by Cdk/
Clb kinases in the run-up to metaphase. Cdc14 is kept inactive in
early M phase by binding to a stoichiometric inhibitor Net1, found
in the nucleolus. The Cdc14/Net1 complex is known as RENT
(regulator of nucleolar silencing and telophase) [33,34]. At ME,
both Pds1 and Net1 must be neutralized. Pds1 is degraded by
proteasomes after polyubiquitination by the Cdc20/APC com-
plex. Net1 is inactivated by phosphorylation by FEAR and MEN.
In metaphase, even though Cdk/Clb2 and Cdc5 are actively
phosphorylating Net1, Net1 is kept active by a powerful
phosphatase Cdc55/PP2A [17,35,36].
When all chromosomes are correctly aligned on the mitotic
spindle, Cdc20/APC becomes active and initiates degradation of
both Clb2 and Pds1. Degradation of Pds1 releases Esp1, which
promotes anaphase (its catalytic activity as a protease). Esp1 has a
second, non-catalytic function to inhibit PP2A, allowing Cdk/
Clb2 and Cdc5 to phosphorylate Net1 and release Cdc14.
The regulation of Tem1 is more complicated than indicated in
Figure 1. Tem1 is a G-protein, i.e., it is active when bound to GTP
and inactive when GTP is hydrolyzed to GDP [37]. GTP
hydrolysis is promoted by the Bub2/Bfa1 complex and GDP-GTP
exchange is promoted by Lte1 [29,38]. By phosphorylating and
inactivating Bfa1, Cdc5 activates Tem1 [39,40]. Contrariwise,
PP2A and Cdc14 dephosphorylate Bfa1 and inactivate Tem1
[17,20,41]. In addition, Tem1 activation is promoted at anaphase
II (spindle elongation), when Lte1 is brought into contact with
Tem1 by migration of the daughter spindle pole body to the bud
cortex [29]. In the present model, we simplify this mechanism by
introducing Tem1i and Tem1a (inactive and active), and
associating Tem1 activation to Cdc5 and ‘‘S’’ (spindle elongation),
and Tem1 inactivation to PP2A and Cdc14.
Cdc15 activity is regulated by phosphorylation and dephos-
phorylation (Figure 1). Cdc15 is phosphorylated (inhibited) by
Cdk/Clb2 and dephosphorylated (activated) by Cdc14. Hence,
FEAR-induced Cdc14 release may promote MEN activation
through Cdc15 dephosphorylation [28,42–44]. The positive
feedback loop between Cdc14 and Cdc15 keeps MEN active,
which sustains Cdc14 release until Cdh1 is fully activated [17].
Cdh1 activity is also regulated by phosphorylation and
dephosphorylation (Figure 1). Cdh1 is inactive in metaphase
because it is strongly phosphorylated by Cdk/Clb2. During ME,
Cdh1 is activated when the rising phosphatase activity of Cdc14
overcomes the falling kinase activities of Clb2 and Cdc5
[32,45,46]. Because Cdh1/APC degrades Clb2 and Cdc5, it
establishes the newborn cells in G1 phase after ME.
Progression through exit from mitosis and the temporal order of
late mitotic events depend, at least in part, on the order in which
different Cdk and APC targets are dephosphorylated and
destroyed [47]. Both Cdc14 and PP2A dephosphorylate Net1
[17,33,35,36,42]. Early dephosphorylation of Cdc15 may be a
problem for the proper organization of ME events by early
activation of MEN. Hence, we assume that PP2A, which is high in
metaphase and in early anaphase, does not dephosphorylate
Cdc15. Rather, Cdc14 activates MEN by dephosphorylating
Cdc15 [28,42–44], after activation of the FEAR pathway. PP2A
and Cdc14 dephosphorylate Bfa1 and inactivate Tem1 [17,20,41].
To simplify quantitative description in the model, Tem1 is
inactivated by PP2A/Cdc55 and Cdc14 rather than acting
through GAP and GEF. Cdh1 is activated by Cdc14 in late
anaphase by dephosphorylation when PP2A is low [46,48,49].
Figure 1 summarizes this introduction in the form of a
hypothetical wiring diagram of the molecular interactions
controlling ME in budding yeast. We use mathematical modeling
to assess the adequacy of this wiring diagram to account for known
facts about ME in wild-type and mutant budding yeast cells. The
model also makes predictions about the phenotypes of novel
mutants that have not yet been characterized experimentally, and
these mutant properties can serve as independent tests of the
wiring diagram. Our modeling methods are described briefly in
the accompanying ‘‘Methods’’ section. The mathematical equa-
tions that describe the dynamics of the molecular interactions in
Figure 1 are given in Table S1.
The model describes the regulation of Cdc14 in wild-type
cells
In Figure 2 we simulate ME events based on the differential
equations in Table S1, the ‘basal’ set of rate constants for wild-type
cells (Table S2), and the initial conditions (Table S3) that represent
a cell arrested in metaphase. In this paper, ‘wild type’ refers to cells
of the mutant strain cdc20DGAL-CDC20, which can be arrested in
metaphase by Cdc20-depletion (growth on glucose) and then
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from glucose to galactose medium) at t=0. In Figure 2, as in all
simulations, we plot the (scaled) concentrations of representative
proteins: Clb2, Cdc5, Cdc14 (released), Cdh1 (active), etc. The
simulation is in good agreement with experimental observations of
ME in wild-type cells [17]. During metaphase arrest by Cdc20-
depletion, Cdc14 is sequestered in RENT, MEN activity is
negligible, and all phosphorylated forms of Net1 and RENT are
small. The steady state levels of Clb2, Cdc5, Net1, RENT and
PP2A are at their peak values, close to 1 (arbitrary unit).
The metaphase-arrested state is very dynamic, with rapid rates
of phosphorylation and dephosphorylation of Net1, due to high
activities of kinases (Cdk/Clb2 and Cdc5) and the opposing
phosphatase, PP2A (Flux diagrams are presented in Figure 3). In
metaphase, Cdc5 activity is high, and it continuously phosphor-
ylates RENT to PRENT, which rapidly dissociates into Cdc14
and PNet1. At the same time, high activity of Cdk/Clb2
phosphorylates Net1 subunits to PRENTP, which also dissociates
rapidly to Cdc14 and PNet1P. Nonetheless, PP2A activity is also
high in metaphase, and this phosphatase converts PNet1 and
PNet1P to Net1. Under these conditions, there is an excess of
Net1, which avidly captures free Cdc14, sequestering it back into
RENT. The dynamic balance among these fluxes in metaphase
(Figure 3) maintains high steady state levels of Net1 and RENT,
and low levels of the phosphorylated forms of these proteins.
This dynamic balance is disturbed at the metaphase-anaphase
transition (t=0 in Figure 2) by the production of Cdc20, which has
several consequences. (1) By degrading a fraction of Clb2 (,40%),
it lowers both Cdk and Cdc5 activities. (2) By degrading Pds1, it
releases Esp1 to down-regulate the activity of PP2A. (3) The
phosphatase activity drops much more than the kinase activities,
causing net phosphorylation of Net1 subunits and release of Cdc14
from RENT complexes. (4) Cohesin cleavage by Esp1 leads to
spindle elongation (S=1) and activation of Tem1. Because these
processes are self-reinforcing, there is an abrupt release of Cdc14
from the nucleolus about 10 min after the onset of Cdc20 synthesis
(transfer to galactose medium).
Tem1 activation alone is insufficient for MEN activity; Cdc15
must be activated as well, and this requires FEAR-mediated
release of Cdc14. Active MEN now contributes to phosphorylation
of RENT and RENTP into PRENT and PRENTP, from which
Cdc14 is further released in a sustained manner during anaphase
and telophase. Cdc14 reaches its peak (0.6) around t=15 min and
stays at peak level for ,10 min. Notice that in our model fluxes
are much higher along the route RENTRPRENTRPRENTP
than along the route RENTRRENTPRPRENTP, which sug-
gests that Cdc5 phosphorylation may prime Net1 for phosphor-
ylation by Cdk/Clb2, rather than vice versa.
After MEN activation, the fluxes from RENT to PRENT and
from PNet1 to Net1 intensify; thus, PNet1 stays relatively low
while PNet1P is high. Eventually the Cdc14:Clb2 ratio becomes
large enough to activate Cdh1. Active Cdh1 completes the
ubiquitination and degradation of Clb2, as well as promoting the
degradation of Cdc5 and Cdc20. Loss of Cdc20 results in re-
accumulation of Pds1, which inhibits Esp1, allowing PP2A
phosphatase activity to go back up. High PP2A activity and free
Cdc14 turn PNet1P into Net1, which captures the remaining
Figure 2. Numerical simulation of exit from mitosis in wild-type
cells. The four panels show the time courses of ME regulators during a
typical Cdc20 ‘block and release’ experiment, which is simulated as
follows: the simulation starts at t=215 min under metaphase-block
conditions (cdc20D GAL-CDC20 in glucose; ks,20=0), and then Cdc20
synthesis is induced (transfer to galactose; ks,20=0.015) at t=0. During
the Cdc20-block phase (t,0), free Cdc14 is low due to sequestration by
Net1 in RENT, MEN is inactive, and Net1 and RENT are predominantly
dephosphorylated because of high activity of PP2A. The steady state
levels of Clb2, Cdc5, Net1, RENT and PP2A are close to 1 (arbitrary unit).
doi:10.1371/journal.pone.0030810.g002
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dependent on both Cdc14 and PP2A phosphatase activities.
The binding rate of Cdc14 to Net1 is quite high and the
unbinding rate is low, making RENT the most stable complex
relative to the others. In RENTP, Cdc14 binding rate to Net1P is
much lower than the binding to Net1 in RENT, but it is ten orders
of magnitude higher than the binding in PRENT and PRENTP;
in addition, the unbinding rate is low as in RENT. Hence,
RENTP is a much more stable complex than either PRENT or
PRENTP. Because the dissociation rates of PRENT and
PRENTP are large, Cdc14 is released from PRENT and
PRENTP during anaphase and telophase.
The variable S (spindle elongation) starts to drop after Cdh1
reaches 0.3 around 23 min, at which time we assume cytokinesis
occurs. (The quantitative criterion for ME in our model is that
Cdh1 increases above 0.3.) At t=35 min, Cdh1 is fully active and
PP2A is high, while Cdk/Clb2, Cdc5 and MEN activities are close
to zero, and Cdc14 is sequestered back in the nucleolus. The
system has come to the G1 steady state, where all the fluxes are
negligible, Cdh1 is active, the levels of RENT, Net1, Cdc15, and
PP2A are close to 1, and the concentrations of all other model
variables are close to zero.
For all our model simulations, we indicate the figure presenting
the particular model simulation, such as ‘‘simulated in Figure 4D’’,
and the paper presenting the simulated experiment(s), with a
literature citation. If any statement in the paper does not include
‘‘simulated in Figure number’’, then it is either our proposal or
claim (if no reference is given) or an experimental finding (if a
reference is given).
The mathematical model must be consistent not only with the
properties of ME in wild-type cells but also with the phenotypes of
budding yeast strains that carry mutations in ME genes. To test
our model, we simulate ME mutants of yeast using exactly the
same differential equations, parameter values, and initial condi-
tions as for wild-type cells (Tables S1, S2, and S3), except for those
modifications to parameters dictated by the particular mutation
being simulated (see model web page). We describe the most
informative mutants in the text, we provide additional information
in the Supporting Information, and we provide a full account of all
mutant simulations on the web page that supports this paper
(http://mpf.biol.vt.edu/research/mitotic_exit_model/pp).
Cdc5 is necessary and sufficient for Cdc14 release
That Cdc5 is necessary for Cdc14 release is demonstrated by
the cdc5-as1 mutant (simulated in Figure 4A), for which Polo
activity is very low, Net1 is not phosphorylated, and Cdc14 is not
released [20]. Cdc14 is retained in RENT in our simulations, and
the fluxes are negligible. Cdc5 has many other roles in addition to
Cdc14 release in anaphase. Cdc5 may regulate microtubule
function, spindle orientation, and migration [50]. cdc5-as1 cells are
arrested in telophase with short mitotic spindles [49,51], large
buds, separated DNA masses, and elevated Cdk/Clb2 activity
[50]. In a majority of anaphase cdc5-as1 cells, spindle elongation
occurred entirely in the mother cell, rather than through the bud
neck, which implies a failure of the nucleus to migrate into the bud
[50]. Thus, Tem1 may be prevented from gaining access to Lte1
[39] and stays inactive. Since Cdc5 has significant impact on
spindle elongation, Tem1 activation by S depends on Polo in our
model equations.
Overexpressed Cdc5 can promote Cdc14 release and ME when
both MEN and FEAR are inactive. In the mutant GAL-CDC5
cdc15-2, Cdc5 can be overexpressed in the absence of Cdc15
activity, allowing Visintin et al. [30] to show that overexpressed
Cdc5 can induce Cdc14 release when MEN is inactive (simulated
in Figure 4B). The GAL-CDC5 cdc15-as1 GAL-PDS1-mdb mutant
[20] shows that overexpressed Cdc5 is sufficient to promote Cdc14
release when both MEN and FEAR are inactive, because Cdc15 is
inactive and Pds1 is abundant (simulated in Figure 4C). In this
figure, Clb2 is elevated due to inactive Cdc2 (In these experiments,
cells are arrested in S phase by hydroxyurea, which blocks the
activation of Cdc20). High Clb2-kinase activity blocks ME
(activation of Cdh1), and Cdc14 is not re-sequestered to the
nucleolus. When Cdc20 is active, as in mad1D cdc15-2 GAL-CDC5
cells [30], ME and Cdc14 release occur with almost the same
kinetics as wild-type cells (simulated in Figure 4B). Even though
MEN is inactive, overexpressed Cdc5 is sufficient for Cdc14
release and ME. Cdc5 is dispensable when MEN is hyperactivated
by overexpression of a truncated version of Cdc15 (see Figure 4D),
which may explain the phenotype of the met-cdc5-repress GAL-
CDC15[1-750] mutant strain [30].
In contrast to other MEN mutants (simulated in Figure 4E),
Cdc14 is not transiently released in cdc5-1 cells [52], and Net1 is in
a hypophosphorylated form in telophase arrest [21] because of the
greatly reduced Polo activity. Net1 is not phosphorylated in the
Figure 3. Flux diagrams in wild-type cells. Initially cells are in the
metaphase steady state by Cdc20 deprivation. Cdc20 activation at time
zero (ks,20=0.015) induces mitotic progression through anaphase,
telophase and G1. Flux definitions are given in Table S1.
doi:10.1371/journal.pone.0030810.g003
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Cdc14 release in cdc14-1 may be attributable only to Net1
phosphorylation by Cdc5.
The model predicts that after Cdc20 addition GAL-CDC5 cdc15-
2 NET1-6cdk mutant cells exit from mitosis with a delay, but GAL-
CDC5 cdc15-2 GAL-PDS1 cells are arrested in telophase (see model
webpage). In GAL-CDC5 cdc15-2 GAL-PDS1, Cdc14 is transiently
released and returns to the nucleolus because Cdk activity is
reduced due to degradation of Clb2 by Cdc20, which causes Polo
activity to go down. Hence, Cdc14 release can no longer be
sustained.
FEAR promotes transient Cdc14 release in early anaphase
Mutants defective in MEN components, such as cdc15-2, tem1-3,
and dbf2-2, are arrested in telophase with elongated spindles. After
a transient release in early anaphase (simulated in Figure 5A and
Figure 5B), Cdc14 is tightly sequestered in the nucleolus
[33,34,52,53]. In MEN mutants (e.g. cdc15-2 in Figure 5A), the
initial time of FEAR-induced Cdc14 release is about 11 min in our
simulation, as in experiments [52]. Clb2 is degraded to almost half
its mitotic level by Cdc20 [54] but no further because Cdh1
remains inactive. Cdc15 is transiently activated in dbf2-2 mutants;
however, it stays inactive in cdc14-3 [52], confirming that FEAR-
Figure 4. Simulation of mitotic progression of cells containing overexpressed CDC5 and inactive cdc5 mutations. (A) Cdc5 is necessary
for ME. Cdc20 block-and-release was simulated as in Figure 2 with inactive Cdc5 (cdc5-as1; effpol=0). Cdc14 is not released, nor is Cdh1 activated. (B)
The MEN requirement for ME can be bypassed by overexpressed Cdc5. Cdc20 block-and-release was simulated as usual, with inactive Cdc15 (cdc15-2;
effc15=0) and with Cdc5 overexpressed 30-fold (GAL-CDC5; ks,polo=0.3). (C) Overexpressed Cdc5 is sufficient for Cdc14 release when FEAR and MEN
are inactive. Simulation was started in an arrested steady state with initial conditions of Clb2 and Polo were set less than metaphase values to
represent an earlier stage of the arrest by hydroxyurea (Clb2=0.8, Polo=0.6, Poloi=0.2, ks,b2=0.024, ks,polo=0.006) and with inactive Cdc15
(effc15=0) for 15 min. Then Cdc5 and Pds1 overexpressions were induced at time zero (ks,polo=0.3, ks,pds=0.45, kd,pds9=0). (D) The Cdc5 requirement
for Cdc14 release and ME can be bypassed by overexpression of a truncated version of Cdc15. Cdc20 block-and-release was pre-simulated for 60 min
with no synthesis of either Cdc20 or Cdc5 (ks,polo=ks,20=0; setting also the initial conditions for Cdc5 active and inactive forms to zero) while the total
concentration of Cdc15 was increased 20-fold and inhibition of Cdc15 by Cdk was reduced 1000-fold (ki,c159=0.00009, CDC15T=20). At t=0, Cdc20
synthesis is induced as usual (ks,20=0.015). (E) Cdc14 is not released in cdc5-1 and cdc5-1 cdc14-1 cells in E and F. Therefore, Cdc14 release in the
cdc14-1 mutant may be attributable solely to Net1 phosphorylation by Cdc5. Simulation in E was done similar to Figure 4A except that effpol was set
to 0.1 for the small residual activity of Cdc5. (F) Simulation in F was done similar to A except that activity of Cdc14 was set to zero (effc14=0).
doi:10.1371/journal.pone.0030810.g004
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its ability to activate MEN [42].
In cells carrying the NET1-6cdk mutation, where all Cdk
phosphorylation sites on Net1 are mutated [55], ME is delayed by
about 13 min, similar to other FEAR defective mutants in our
simulations (simulated in Figure 5C). In NET1-6cdk mutant cells,
Cdc5 phosphorylates Net1 and RENT after PP2A drops at
anaphase onset. Cdc14 is released from PRENT only, because
Net1 cannot be phosphorylated by Cdk/Clb2. This causes
prolonged Cdc14 release induced by Cdc5 and MEN before
ME. NET1-6cdk cells are considered FEAR mutants because
NET1-6cdk cdc15-2 cells [55] fail to exhibit FEAR-release of Cdc14
Figure 5. Simulations of mitotic progression of cells containing cdc15-2, NET1-6cdk, tem1-3, cdc28-as1, and GAL-CLB2dbD cdc5-as1
mutations. (A) In MEN mutants such as cdc15-2, Cdc14 is transiently released and resequestered. Cdc20 block-and-release was presimulated with
inactive Cdc15 (effc15=0). (B)I ntem1-3 temperature sensitive mutant (MEN inactive), Cdc14 is transiently released and cells are arrested in telophase.
Simulation was started at metaphase by Cdc20 deprivation (ks,20=0) for 15 min with total concentration of Tem1, initial conditions of Tem1 and MEN
were set to zero. Cdc20 was activated at time zero (ks,20=0.015) (C)I nNET1-6cdk cells ME occurs with a delay, as typical of FEAR mutants. Cdc20
block-and-release was presimulated with no Net1 phosphorylation by Cdk/Clb2 (kk,12=kk,34=0). (D) Double MEN and FEAR mutations, such as NET1-
6cdk cdc15-2, do not show transient release of Cdc14 and arrest in telophase. Cdc20 block-and-release was presimulated with inactive Cdc15
(effc15=0) and no Net1 phosphorylation by Cdk/Clb2 (kk,12=kk,34=0). (E) When Cdk kinase activity is inhibited, there is no Cdc14 release. Both Cdk/
Clb2 and Cdc5 phosphorylation on Net1 are diminished in cdc28-as1 mutant. Simulation was done similar to wild-type cells except that INH was set
to 5 to inhibit Cdk kinase activity. (F) Our model predicts that when Cdc5 is inhibited, overexpressed Clb2 cannot induce Cdc14 release with or
without active Cdc20. Simulation was started at metaphase by Cdc20 deprivation, overexpression of Clb2 and inactive Cdc5 for 15 min (ks,20=0,
ks,b2=0.6, kd,b2=kd,b29=effpol=0). Cdc20 was added back at time zero (ks,20=0.015).
doi:10.1371/journal.pone.0030810.g005
A Model of Mitotic Exit in Budding Yeast
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e30810(simulated in Figure 5D) in the absence of Cdk/Clb2 and MEN
phosphorylation on Net1.
Clb2-dependent phosphorylation of Net1 is also absent in
strains carrying the cdc28-as1 allele (encoding Cdk1 protein that
can be inhibited by the drug 1NM-PP1). Chemical inhibition of
Cdk1 kinase activity causes inactivation of Cdc5, which results in
elimination of Net1 phosphorylation and Cdc14 release (simulated
in Figure 5E) [55]. Therefore, Cdk/Clb2 phosphorylation is
important for the timely exit from mitosis and contributes to
FEAR-release of Cdc14; however, unlike Cdc5, Cdk1 is not
playing an essential role for FEAR. Our model predicts that when
Cdc5 activity is inhibited, as in cdc5-as1 GAL-CLB2-dbD cells,
RENT is phosphorylated by Cdk/Clb2 to RENTP, which does
not readily dissociate; thus, overexpression of Clb2 protein cannot
induce Cdc14 release in the absence of Cdc5 activity (simulated in
Figure 5F).
The flux diagrams for NET1-6cdk and cdc15-2 mutant cells are
shown in Figure 6 and Figure 7, respectively. Figure 7 shows that,
after anaphase onset, fluxes in the path RENT?PRENT?-
PRENTP are increased because of high Cdc5. Fluxes through
RENT?RENTP?PRENTP do not play a major role in the
transient release of Cdc14 because of higher phosphatase activity
in this path (as in wild-type cells). In cdc15-2 cells, Net1 gets
phosphorylated first by Cdc5 and then by Cdk/Clb2 in our model,
and Cdc14 gets released from PRENT and PRENTP. At
telophase arrest, all variables reach their steady state values where
some portion of Net1 stays in the phosphorylated form, and kinase
activities are reduced to about half of their metaphase levels.
Cdc14 reaches a peak value, which is less than half of its peak in
wild-type cells, before it is sequestered back into RENT. RENT
returns to metaphase levels, and PRENT stays a little elevated due
to remaining Cdc5 activity. PNet1P and PNet1, released from
PRENT and PRENTP, are dephosphorylated by Cdc14 and
move back to RENT after capturing free Cdc14.
The model predicts that, after Cdc14 transient release in cdc15-2
cells, inhibition of Cdc14 phosphatase activity results in an
elevated level of Cdc14 protein released in telophase (Figure 8A);
however, inhibition of PP2A activity has no such effect on Cdc14
release (Figure 8B). When both Cdc14 and PP2A phosphatase
activities are inhibited the effect is similar to the inhibition of
Cdc14 (Figure 8C). Therefore, in our model Cdc14 itself is
responsible for its own re-sequestration after its transient release in
MEN mutants. FEAR-released Cdc14 in MEN mutants cannot
induce ME because the Cdc14/Clb2 ratio stays below the critical
threshold to activate Cdh1.
Both proteolytic and nonproteolytic activity of Esp1
contributes to ME
Overexpressed separase is sufficient to trigger Cdc14 release
(simulated in Figure 9A) in cells arrested in metaphase by
depletion of Cdc20 [17,56,57]. These authors used the attenuated
GALS promoter to overexpress Esp1, which allows viability and
ME at 30uC. Cdc14 release in overexpressed Esp1 depends on
Cdc5 activity (simulated in Figure 9B). GALS-ESP1 cells do not exit
from mitosis at 23uC as judged by cytokinesis and entry into the
next cell cycle. Clb2 remains high because Cdc20 is inactive, and
the Cdc14/Clb2 ratio may stay lower than the threshold to
activate Cdh1. We are not exactly sure how temperature changes
the phenotype. Temperature may alter the specific activity of
Figure 6. Flux diagrams and temporal changes of RENT, Net1
forms in NET1-6cdk mutants. Simulation was done similar to
Figure 5C.
doi:10.1371/journal.pone.0030810.g006
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23uC, which is unable to counteract all mitotic Cdk activity. In
fact, when Cdk activity is reduced by deleting CLB5 (simulated in
Figure 9C) in GAL-ESP1 cells, ME occurs in the absence of active
Cdc20, as judged by cytokinesis and subsequent cell cycle [56]. In
the simulation of GAL-ESP1 at 23uC, we reduce by one-half the
degradation rate of Clb2, resulting in higher Clb2, which prevents
cells from exiting mitosis.
Esp1 is a protease that triggers chromosome segregation at
anaphase onset by cleaving cohesin rings. Moreover, Esp1
downregulates PP2A by its nonproteolytic activity, allowing
Cdc5 and Cdk kinases to phosphorylate Net1 and induce Cdc14
release. Our model incorporates both proteolytic and nonproteo-
lytic functions of Esp1; nonproteolytic function of Esp1 leads to
FEAR activation [17,56], and its proteolytic activity is necessary
for spindle elongation and MEN activation [57]. When Esp1 is
inactive as in esp1-2
td mutant (simulated in Figure 9D), there is no
Cdc14 release, no cohesin cleavage, and no spindle elongation,
resulting in inactive FEAR and MEN. Thus, cells fails to undergo
cytokinesis, ME is blocked and cells remain arrested in mitosis
[17,58,59].
Figure 10A shows that Cdc14 is prematurely released in cdc55D
cells arrested in metaphase by depletion of Cdc20 [17,35,36]. The
Cdc14 release in metaphase occurs due to high kinase activities
Figure 7. Temporal changes of RENT, Net1 forms and fluxes in
cdc15-2 cells blocked at telophase in mitosis. Simulation was done
similar to Figure 5A.
doi:10.1371/journal.pone.0030810.g007
Figure 8. Model predicts that Cdc14 is responsible for its own
re-sequestration after ME. (A–C) All simulations were done similar
to cdc15-2 mutant simulations in Figure 5A except that after 20 min
either Cdc14 (in A, effc14=0) or PP2A (in B, effppa=0) or both (in C,
effc14=effppa=0)) were inactivated by setting their corresponding
activity factors to zero.
doi:10.1371/journal.pone.0030810.g008
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by PP2A phosphatase activity. As we discuss in the following
section, PP2A/Cdc55 promotes resequestration of Cdc14; thus,
Cdc14’s return to the nucleolus after ME is delayed in cdc55D cells
[17]. In bub2D cells arrested in metaphase by depletion of Cdc20
(simulated in Figure 10B), Cdc14 is released prematurely mainly
by MEN and returned with a delay [17,20]. Overexpression of
Clb2, which cannot be degraded by Cdc20 or Cdh1, promotes
Net1 phosphorylation in cells arrested in metaphase (Figure 10C)
but not in G1 cells (Figure 10D).
Return of Cdc14 to the nucleolus depends on Cdc5
degradation and phosphatase activity
What is the mechanism promoting Cdc14 re-sequestration into
the nucleolus after ME? At the onset of anaphase, kinase activities
overcome phosphatase (PP2A) activity, and Cdc14 is released from
both PRENT and PRENTP. As long as kinase activities remain
high and PP2A activity is low (simulated in Figure 11A), Cdc14
remains released from the nucleolus [20]. So, either inactivation of
kinases or elevated levels of PP2A after ME may contribute to
Cdc14 return to the nucleolus. First, we investigated the role of
degradation of Clb2 by Cdh1 in the return of Cdc14. Our
simulations in Figure 11B, in agreement with the experiments
[20], show that inhibition of Clb2-kinase activity (by its
stoichiometric inhibitor, Sic1) is not enough to return Cdc14 to
the nucleolus. Second, when we inhibit Cdk activity in telophase-
arrested MET-CDC20 pds1D cdh1D cells, Cdc14 does not return to
the nucleolus as reported in [20]. Therefore, inactivation of Cdk/
Clb does not play a role in the return of Cdc14. Third, we
explored the effect of removing Cdc5 from telophase-arrested
MET-CDC20 pds1D cdh1D cells (simulated in Figure 11C), and
found that Cdc14 returns to the nucleolus, in agreement with
experiments [20]. Hence, Cdc5 is needed to sustain Cdc14 release
during anaphase and telophase.
Simulations in Figure 12A–B show that the return of Cdc14 is
delayed in 36CDC5DN70 and in bub2D 36CDC5DN70 mutants
when a proteolysis–resistant version of Cdc5 is expressed
(CDC5DN70 lacks destruction boxes) [20], confirming the
importance of Cdc5 degradation for Cdc14 return. The
degradation of Polo at ME not only reduces Net1 phosphorylation
(by lowering the fluxes going into PRENT and PRENTP), but also
inactivates Tem1 which in turn inactivates MEN. These effects are
sufficient for returning Cdc14 to the nucleolus in wild-type cells.
Finally, in Figure 12C–F we investigate the roles of Cdc14 and
PP2A phosphatase activities on Cdc14 re-sequestration after ME.
Cells lacking Cdc14 phosphatase activity (cdc14-1) are arrested in
telophase with elevated release of Cdc14 protein, low PP2A
activity, and hyperphosphorylated Net1, in agreement with [55].
When we inhibit both PP2A and Cdc14 right after ME (simulated
in Figure 12F), the model predicts that Cdc14 stays out, Cdh1 is
on, and MEN turns off. When either Cdc14 or PP2A activity is
inhibited after ME, the model predicts return of Cdc14 to the
nucleolus with a delay (simulated in Figure 12D–E). Therefore,
although either Cdc14 or PP2A is sufficient for re-sequestration of
Cdc14 into RENT complexes, both Cdc14 and PP2A are needed
for the timely return of Cdc14 to the nucleolus in wild-type cells.
Figure 9. Mitotic progression of cells containing an ESP1 mutation. (A) In metaphase arrested cells at 23uC, overexpression of Esp1 induces
Cdc14 release; however, cells do not exit from mitosis, and Cdh1 stays inactive. Cells are presimulated in metaphase arrest by Cdc20 deprivation, then
at t=0 the rate of synthesis of Esp1 is increased 60-fold (ks,esp=0.078), with the rate of Clb2 degradation at 23uC assumed to be half its basal value
(kd,b20=1.5). (B) Cdc14 release is dependent upon Cdc5 in nocodazole-arrested cells; when CDC5 is deleted, overexpressed Esp1 can no longer induce
Cdc14 release. Cells are presimulated in metaphase arrest by nocodazole (N=1) with no synthesis of Cdc5 (ks,polo=0) and no initial Cdc5 proteins.
Then at t=0 the rate of synthesis of Esp1 is increased 60-fold (ks,esp=0.078). (C) When CLB5 is deleted, overexpressed Esp1 can induce ME. Reduction
in Cdk activity by Clb5 deprivation allows for ME by increasing the phosphatase-to-kinase ratio, leading to activation of Cdh1. Simulation was done as
in panel A, except that the synthesis rate of Clb2 was set to 80% of its basal value (ks,b2=0.024). (D) When Esp1 is inactive, Cdc14 cannot be released
and the cell cannot exit from mitosis. It is assumed that separase is absent in esp1-2
td mutant cells (ks,esp=0). During the 120 min pre-simulation of
Cdc20 block in metaphase, the rate of degradation of Esp1 was increased 10-fold, and the activity of Esp1 was lowered 10-fold. (effesp=0.1,
kd,esp=0.028,). At t=0, Cdc20 synthesis was induced, as usual.
doi:10.1371/journal.pone.0030810.g009
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not return to the nucleolus.
Cdc5 may phosphorylate Net1 in vivo to promote Cdc14
release
Cdc5 plays multiple roles during the cell cycle. As a component
of MEN, Cdc5 promotes ME by phosphorylating (inhibiting) Bfa1,
a negative regulator of MEN [39]. Since Cdc14 is transiently
released in all MEN mutants except cdc5, Cdc5 is also a
component of FEAR [44,52]. In this section we present evidence
that Cdc5’s role in FEAR is to phosphorylate Net1.
Net1 is extensively phosphorylated by Cdc5 in vitro [23], and
Cdc5 seems to influence the phosphorylation state of Net1 in vivo
[23]. Cdc5 co-exists with Net1 in the nucleolus and may reduce
the affinity between Net1 and Cdc14 [22]. In a cdc5 mutant (msd2-
1), Net1 is not phosphorylated and Cdc14 is not released from the
nucleolus during anaphase. Net1 is highly phosphorylated in
nocodazole-arrested cells that are overexpressing Cdc5-dbD (a
stable mutant form of Cdc5) [22], suggesting that Cdc5
phosphorylates Net1 in vivo.
When cells are arrested in metaphase by nocodazole [56], Cdc5
triggers Cdc14 release independently of Slk19, Esp1, Spo12, and
other FEAR components, suggesting that Cdc5 has additional
roles in ME beyond its phosphorylation of Bfa1. This result is
confirmed by [55]. The additional role of Cdc5 to promote Cdc14
release may be the direct phosphorylation of Net1 because other
known roles of Cdc5 are irrelevant. Cdc5’s role in activating Tem1
and MEN is irrelevant under these conditions, because [23]
showed that overexpression of Tem1, Cdc15, and Dbf2/Mob1
does not cause Cdc14 release in nocodazole-arrested cells. In fact,
CDC5 is the only gene whose overexpression causes premature
release of Cdc14 during metaphase [23]. Overexpression of a
proteolysis-resistant protein (GAL-CDC5-dbD) promotes Cdc14
release from the nucleolus in cells with short spindles after release
from a-factor (Clb2 is low) or in cells arrested in metaphase by
nocodazole (Clb2 is high) [23]. Therefore, overexpressed Cdc5
may induce Cdc14 release by phosphorylating Net1 independent
of Clb2-kinase activity and independent of Cdc5’s role in MEN or
in cohesin cleavage and spindle elongation.
Overexpression of a stabilized form of Clb2, which cannot be
degraded by Cdc20 or Cdh1, promotes Net1 phosphorylation and
dispersal of Cdc14 in cells arrested in metaphase (simulated in
Figure 10C) but not in G1 cells (simulated in Figure 10D)
(compare Figure 4 in [55]). Because Cdc5 and MEN are inactive
in G1 cells, this is further evidence that Clb2-dependent
phosphorylation of Net1 alone is insufficient to convert Net1 into
the inactive, phosphorylated form that releases Cdc14. The
inactive form of Net1 may require phosphorylation by Cdc5 or
MEN. According to our model (Figure 1), in the absence of Cdc5
activity, high Clb2 may phosphorylate RENT (converting it to
RENTP), but Cdc14 is not released from this complex, as
evidenced by these experiments.
On the other hand, in the absence of Clb2-dependent
phosphorylation of Net1, as in the NET1-6cdk mutant strain
Figure 10. Mitotic progression of cells containing CDC55, CLB2 and BUB2 mutations. (A) In the CDC55 deletion strain, Cdc14 is re-
sequestered with a delay. Cdc20 block-and-release was simulated as usual, with [PP2A]total=0. (B) Cdc14 is released prematurely in bub2D cells.
Cdc20 block-and-release was pre-simulated with the rates of Tem1 inactivation by Cdc14 and PP2A set to zero (ki,tem9=ki,tem0=0). (C) In a nocodazole-
arrested cell, overexpression of Clb2 induces Cdc14 release, and the cell arrests in telophase. Pre-simulation was done by setting N=1 for 15 min. At
t=0, the rate of synthesis of Clb2 was increased 20-fold and the rates of degradation of Clb2 were set to zero (N=1,kd,b29=kd,b20=0,ks,b2=0.6). (D)
Cdc14 is not released when Clb2 is overexpressed in G1 cells with Cdc5 inactive. This simulation was started from G1 initial conditions (low levels of
Clb2, Cdc5 and Cdc14). At t=0, the initial condition of Polo is set to 0.01, the synthesis rate of Clb2 is set to a large value and its degradation rate is
set to zero (kd,b29=kd,b20=ks,polo=0,ks,b2=0.6).
doi:10.1371/journal.pone.0030810.g010
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are still able to activate Cdc14 and exit from mitosis. As depicted
in Figure 1, Cdc5 can still phosphorylate and inactivate RENT in
the absence of Cdk/Clb2 phosphorylation of Net1.
Moreover, hyperphosphorylation of Net1 in cdc14-1 cells is
significantly reduced upon inactivation of Cdc5 [23,55]. This
hyperphosphorylation is not a consequence of MEN activity, since
Cdc15 activity is low in cdc14-1 cells. Hyperphosphorylation of
Net1 could be a consequence of Cdc5 and/or Cdk activity. Since
Net1 is not phosphorylated in the cdc5-1 cdc14-1 double mutant
(simulated in Figure 4F) [55], Cdc14 release in cdc14-1 may be
attributable solely to Net1 phosphorylation by Cdc5.
Overexpression of Esp1 induces Cdc14 release in cells arrested
in metaphase by nocodazole [17,20,30,56]. When Cdc5 is
inhibited (GAL-ESP1 cdc5as-1), Cdc14 is no longer released
(simulated in Figure 9B) [20]. Although PP2A activity is very
low (due to high levels of Esp1), Net1 phosphorylation by
endogenous Cdk/Clb2 alone is not sufficient to induce Cdc14
release.
Cells of the cdc20D pds1D cdh1D mutant strain (simulated in
Figure 11A) are arrested in telophase with high Clb2 activity, low
PP2A activity, and elevated release of Cdc14 (see Figure 9 in [20].
After Cdc5 activity is eliminated, Cdc14 returns to the nucleolus,
suggesting that high Clb2 activity alone cannot inactivate Net1 in
the absence of Cdc5 activity.
Considering Net1 phosphorylation in FEAR as dependent only
on Cdk activity would be inadequate to explain the mutant
phenotypes presented above. The facts that Cdc5 is both necessary
and sufficient for Cdc14 release [20], that Cdc5 influences
phosphorylation state of Net1 in vivo [23], that Net1 is extensively
phosphorylated by Cdc5 in vitro [23], and the evidences given in
this section suggest that Cdc5 may promote Cdc14 release by
direct phosphorylation of Net1, as proposed in Figure 1.
The model predicts phenotypes of novel mutants
In each simulation of an experimentally characterized mutant
genotype, we have compared some of our simulation results
against relevant observations. Other details of the simulations may
be considered as predictions, because the experimental studies did
not report the relevant information. These predictions are useful
for future experimental studies of mutant strains that have already
been characterized. In addition, our model can be used to predict
the phenotypes of mutant strains that have not yet been described
in the literature (see Table 1). Our predictions for these novel
mutants are described in detail on our website http://mpf.biol.vt.
edu/research/mitotic_exit_model/pp/index.php.
Discussion
Molecular cell biologists have collected a large amount of data
about the proteins, genes and biochemical reactions involved in
the regulation of mitotic exit (ME) in S. cerevisiae. Using nonlinear
differential equations, we have developed a realistic, quantitative
model of the molecular control system governing ME in yeast
based on this published data. Our model provides an opportunity
to analyze the system-level dynamics of ME events, to investigate
in silico our hypotheses about the molecular machinery of ME, and
to suggest new experiments that test predictions of the model. The
proposed model should be viewed as an evolving hypothesis to be
continually revised and improved based on new observations
about the molecular control of ME in budding yeast.
In particular, our model deals with the release of Cdc14
phosphatase from the nucleolus during anaphase and telophase, as
a result of the kinase activities of Cdk/Clb2 and Polo, the
activation of Esp1 and inhibition of PP2A, sister chromatid
separation and spindle elongation, and the interconnectivity of the
FEAR and MEN pathways. We explored the roles of Cdc5 (Polo
kinase) and Esp1 in FEAR and MEN. We propose that Cdc5
phosphorylates Net1 in vivo, inducing Cdc14 release both in early
and late anaphase. We propose that Cdc5 also activates Tem1 (a
Figure 11. Inactive Clb2 is not required, whereas Polo
inactivation is sufficient for Cdc14 re-sequestration to the
nucleolus. (A) Cells of the triple-deletion strain cdc20D pds1D cdh1D
arrest in telophase with Cdc14 released from the nucleolus. Simulation
was done by setting to zero the rate of synthesis of Pds1, the total
concentration of Cdh1, and the initial conditions of Cdh1, Pds1 and PE
complex (ks,pds=CDH1T=0). (B) After 6 hours of telophase arrest,
cdc20D pds1D cdh1D cells are subjected to Sic1 overexpression, and
Cdc14 does not completely return to the nucleolus. Simulation was
done as in panel A; after 6 hours INH was set to 5 to implement Cdk
inhibition by Sic1. (C)I ncdc20D pds1D cdh1D cells arrested in
telophase, deprivation of Cdc5 causes return of Cdc14 to the nucleolus.
Simulation was done as in panel A; after 40 min the rate of synthesis of
Cdc5 was set to zero and the basal degradation rate of Cdc5 was
increased 10-fold (ks,polo=0,kd,polo=0.1).
doi:10.1371/journal.pone.0030810.g011
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and inactivating Bub2-Bfa1 (Tem1’s GAP), and by promoting
spindle elongation, which brings Lte1 (Tem1’s GEF) into contact
with Tem1. Degradation or inactivation of Cdc5 is sufficient to
silence both FEAR and MEN. Therefore, once Cdc5 activity
drops, Cdc14 returns to the nucleolus. Both Cdc14 and PP2A
phosphatases promote the re-sequestration of Cdc14 into the
nucleolus.
In addition, we integrate both proteolytic and nonproteolytic
functions of Esp1 into the kinetics of ME. FEAR activation
requires the nonproteolytic function (inactivation of PP2A),
whereas MEN activation requires its proteolytic function (cohesin
cleavage, spindle elongation and subsequent activation of Tem1).
Overexpressed Esp1 induces Cdc14 release and ME in the
absence of Cdc20, but it requires Cdc5, an intact spindle, and
MEN activation.
Recently Vinod et al. [19] published a model of ME in budding
yeast focusing on the catalytic and non-catalytic roles of separase
(Esp1) and on Cdc14 endocycles [24,25]. Both Vinod’s model and
our model are based on Queralt et al. [17], but they address
somewhat different aspects of ME in budding yeast. Our model
addresses a broad range of ME experiments (the model webpage
presents more than 100 mutant simulations). Vinod’s model
accounts for Cdc14 oscillations observed in the presence of non-
degradable Clb2 [24,25], but we have been unable to simulate
Cdc14 oscillations under these conditions without compromising
Figure 12. Effects of Cdc5 kinase and of Cdc14 and PP2A phosphatase activities on Cdc14 re-sequestration. A stabilized version of
Cdc5 (36CDC5DN70) causes a delay in Cdc14 re-sequestration both in wild-type cells (panel A) and bub2D background (panel B). (A) Cdc20 block-
and-release was pre-simulated for 180 min with no degradation of Cdc5 (kd,polo9=0,ks,polo=0.011). (B) Simulation was done as in A with the rates of
inactivation of Tem1 set to zero (ki,tem9=ki,tem0=0). (C) Cdc14 stays released from the nucleolus in cdc14-1 cells arrested in telophase. Cdc20 block-
and-release was presimulated with no Cdc14 activity (effc14=0). (D, E and F) Cdc20 block-and-release in wild-type cells; after 24 min (when cells start
to enter G1 phase), either PP2A activity (panel D, effpa=0) or Cdc14 activity (panel E, effc14=0) was inhibited. In either case, Cdc14 is re-sequestered
into the nucleoulus. In panel F, when both PP2A and Cdc14 phosphatase activities are inhibited after 24 min (effpa=effc14=0), Cdc14 does not
return to the nucleolus.
doi:10.1371/journal.pone.0030810.g012
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types. In our opinion, further experimental and modeling studies
are needed to better understand Cdc14 endocycles, to integrate
them into a comprehensive model of the majority of ME mutants,
and to investigate their relevance for yeast cell-cycle control.
Another recent paper [60] presents a model of the anaphase
switch (the metaphase-anaphase transition and its associated
checkpoint) but does not address other details of exit from mitosis.
A reasonable goal for future modeling work will be to incorporate
this model of the anaphase switch into our model of mitotic exit
(borrowing good ideas from Vinod’s model), and then incorpo-
rating the entire ME story into Chen’s 2004 model of the full cell
cycle of budding yeast. At the same time, it will be useful to add a
module describing the morphogenetic checkpoint in the budding
yeast cell cycle (e.g., Ciliberto et al. [61]) and an improved model of
Whi5-SBF interactions at the Start transition (e.g., Barberis et al.
[62]).
Our model of ME in budding yeast organizes a large body of
experimental information in a comprehensive and comprehensible
manner. We believe it provides an accurate and predictive
mathematical description of molecular events regulating ME
events in budding yeast. We hope that this model, together with
other quantitative models of yeast cell cycle controls, will provide a
solid basis to develop models of cell cycle progression in the cells of
higher eukaryotes, including humans.
Methods
Based on a thorough review of the experimental literature and
an earlier model of ME in budding yeast [17], we propose an
extended ‘wiring diagram’ for the molecular regulation of FEAR
and MEN pathways in S. cerevisiae (Figure 1). In the context of
certain standard modeling assumptions (Text S2), we translate the
Figure 13. clb2D and bub2D cdh1D mutants. (A) When Clb2 is
inhibited Cdc14 is released with a delay. Simulation was started at
metaphase Cdc20 block for 80 min with rate of synthesis of Clb2 in the
model decreased to 1/3 of baseline due to residual Clb1 activity
(ks,b2=0.1) and Cdc20 was added back at time zero. (B)I nbub2D cdh1D
cells, Cdc14 stays released after ME. Simulation was done as wild-type
cells except that rates of inactivation of Tem1 and total concentration of
Cdh1 were set to zero (ki,tem9=ki,tem0=CDH1T=0).
doi:10.1371/journal.pone.0030810.g013
Table 1. Prediction of mutant phenotypes.
Genotype Phenotype
GAL-CDC5 Cdc14 starts to be released in metaphase, ME occurs earlier
GAL-CDC5 cdc15-as1 GAL-PDS1 Cdc14 is released transiently and returns back, no ME
GAL-CDC5 cdc15-2 NET1-6cdk Cdc14 is released and cells exit with a delay
GAL-CDC5 GAL-PDS1 Cdc14 is released transiently and returns back, no ME
wild-type then cdc14-3 pp2a Cdc14 stays out after ME although MEN turns off
wild-type then cdc14-3 Cdc14 returns back after ME
wild-type then pp2a Cdc14 returns back after ME
cdc15-2 cdc14-3 Cdc14 is not sequestered back into the nucleolus in telophase arrest
cdc15-2 pp2a ME occurs in cdc15-2 cells after PP2A is inactivated at 20 min
cdc15-2 pp2a NET1-6cdk Cdc14 is not sequestered back into the nucleolus in telophase arrest
bub2D cdh1D GAL-SIC1 Cdc14 re-sequestered back after Cdk inactivation by Sic1
bub2D cdc5-1 no Cdc14 in metaphase, delay in Cdc14 release, ME with a delay
bub2D cdc5-as1 no Cdc14 release, no ME
bub2D NET1-6cdk similar to bub2-del mutant
GAL-ESP1 URL-CDC5 Cdc14 sequestered back after Cdc5 inactivation, no ME
GAL-ESP1 clb2D GAL-ESP1 cells exit from mitosis after Clb2 degradation
GAL-ESP1 cdc15-2 clb2D no ME when MEN is inactive, and Cdc14 stays out
GALS-ESP1 cdc14-3 cdc20D Cdc14 is released, stays out, no ME
GALS-ESP1 NET1-6cdk cdc20D Cdc14 is released, stays out, no ME
GAL-PDS1-mdb cdc55-del ME occurs similar to cdc55-del
CLB2-dbD cdc5-as1 Cdc14 is not released, no ME
Simulations of some of these mutants are provided on the model webpage.
doi:10.1371/journal.pone.0030810.t001
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equations (Table S1) describing the production, degradation,
activation, inhibition, binding, release, phosphorylation, dephos-
phorylation, localization, and delocalization of ME proteins and
physiological variables. The ME proteins tracked by our model
are: Clb2, Cdc5, Cdc14, Cdh1, Cdc20, Esp1, Cdc55/PP2A, Pds1,
Net1, Tem1, and Cdc15. The physiological variables are: C
(cohesin cleavage by separase), and S (spindle elongation driving
sister chromatid separation, after cohesin cleavage). Simulation of
the 18 ODEs in Table S1 requires numerical settings for 59 kinetic
constants (k’s) and 8 binding constants (J’s), and specification of
appropriate initial conditions of the variables. Parameter values
(Table S2) were chosen to provide a good fit of the model to
available experimental observations of wild-type and mutant cells.
We do not assert that this set of parameter values is optimal in any
sense. Initial conditions (Table S3) were chosen to represent steady
state values of model variables in metaphase of wild-type cells.
Given these settings, the ODEs were solved numerically with
two software packages: XPPAut and PET, freely available at
http://www.math.pitt.edu/,bard/xpp/xpp.html and http://
mpf.biol.vt.edu/pet/. For further explanation and justification of
our modeling methods, see [9].
To present our model in a complete and systematic form, we
have developed a website (http://mpf.biol.vt.edu/research/mito-
tic_exit_model/pp/) that includes a full description of the model,
simulations of wild-type cells, model files and all relevant mutants.
The web site is intended to help molecular biologists to design new
experiments and mathematical modelers to explore the model in
greater detail. Text S3 provides a machine-readable file for
reproducing our simulations in other modeling environments.
The phenotypes of relevant mutants were collected from the
literature. To simulate each mutant, we use exactly the same
equations (Table S1) and ‘basal’ parameter values (Table S2)
except for those parameters directly affected by the mutation (see
model webpage).
The standard experimental protocol for studying ME events in
budding yeast is ‘Cdc20 block-and-release’, using the strain cdc20D
GAL-CDC20 (which is ‘wild-type’ for the purposes of this paper).
Cells grown in glucose medium arrest in metaphase because they
are depleted of Cdc20. At t=0, cells are transferred to galactose
medium. The newly synthesized Cdc20 protein is ‘active’ because
the replicated chromosomes have been properly aligned on the
mitotic spindle in glucose medium. Additional mutations are
added on top of the Cdc20 block-and-release strain in the model
exactly as in the experiments. For each of these mutant strains, we
pre-simulate the Cdc20-deletion cells, with the additional
mutations, for 15 min (or as prescribed in the experimental
conditions) and then add back Cdc20 (setting the synthesis rate of
Cdc20 to the wild-type value, 0.015). For a gene deletion, the rate
of synthesis of the corresponding protein is set to zero. For gene
overexpression, an additional constant rate of synthesis of the
corresponding protein is introduced into the equations, because
proteins are typically overexpressed from an extra copy of the gene
under control of an inducible promoter. For temperature-sensitive
mutants, the relevant rate constant(s) retains its wild-type value at
the permissive temperature and is set to zero (or to 10% of its basal
value) at the restrictive temperature. For partial deletions, the
relevant parameter value is assumed to lie between 0 and 100% of
the wild-type (basal) value, according to the experimental
characterization of the mutation.
Supporting Information
Table S1 Differential equations of the model.
(PDF)
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